Inmaculada Lorente-Ruiz

Murcia, MU, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

HLA class-I genotyping to personalize Bacille Calmette-Guerin immunotherapy in bladder cancer.

HLA class-I genotyping to personalize Bacille Calmette-Guerin immunotherapy in bladder cancer.

Journal: Oncoimmunology
Published: December 12, 2025

Immune mechanisms driving clinical heterogeneity in oral lichen planus.

Immune mechanisms driving clinical heterogeneity in oral lichen planus.

Journal: Scientific reports
Published: October 20, 2025

Ethylbenzene Exposure and Bronchoalveolar CD4/CD8 T Cells in Hypersensitivity Pneumonitis Development and Clinical Outcome.

Ethylbenzene Exposure and Bronchoalveolar CD4/CD8 T Cells in Hypersensitivity Pneumonitis Development and Clinical Outcome.

Journal: Biomedicines
Published: October 01, 2025

Interplay of KIR2DL5, nitric oxide, and tobacco smoking in predisposition to bladder cancer.

Interplay of KIR2DL5, nitric oxide, and tobacco smoking in predisposition to bladder cancer.

Journal: Frontiers in cell and developmental biology
Published: May 20, 2025

Diagnostic Utility of Bronchoalveolar Lavage Flow Cytometric Leukocyte Profiling in Interstitial Lung Disease and Infection.

Diagnostic Utility of Bronchoalveolar Lavage Flow Cytometric Leukocyte Profiling in Interstitial Lung Disease and Infection.

Journal: Biomolecules
Published: March 14, 2025

Predictive Value of Flow Cytometry Quantification of BAL Lymphocytes and Neutrophils in ILD.

Predictive Value of Flow Cytometry Quantification of BAL Lymphocytes and Neutrophils in ILD.

Journal: Cells
Published: November 14, 2024

Differential Role of NKG2A/HLA-E Interaction in the Outcomes of Bladder Cancer Patients Treated with M. bovis BCG or Other Therapies.

Differential Role of NKG2A/HLA-E Interaction in the Outcomes of Bladder Cancer Patients Treated with M. bovis BCG or Other Therapies.

Journal: Biomedicines
Published: November 13, 2024

HLA-A*03 may confer protection against long COVID through an enhanced immune response.

HLA-A*03 may confer protection against long COVID through an enhanced immune response.

Journal: Infectious diseases now
Published: October 18, 2024

Neutrophils and Lymphocytes: Yin and Yang of Lung Fibrosis and Patient Outcome in Diffuse Interstitial Lung Diseases.

Neutrophils and Lymphocytes: Yin and Yang of Lung Fibrosis and Patient Outcome in Diffuse Interstitial Lung Diseases.

Journal: Biomedicines
Published: October 01, 2024

Exploring the Immunoresponse in Bladder Cancer Immunotherapy.

Exploring the Immunoresponse in Bladder Cancer Immunotherapy.

Journal: Cells
Published: September 30, 2024

HLA-C*07 is associated with symptomatic HIV-1-associated neurocognitive disorders (HAND) and immune dysregulation.

HLA-C*07 is associated with symptomatic HIV-1-associated neurocognitive disorders (HAND) and immune dysregulation.

Journal: Infectious diseases (London, England)
Published: May 14, 2024
Showing 1-11 of 11

Last Updated: 09/26/2026